This paper provides a comprehensive study of Federated Learning (FL) with an emphasis on enabling software and hardware platforms, protocols, real-life applications and use-cases. FL can be applicable to multiple domains but applying it to different industries has its own set of obstacles. FL is known as collaborative learning, where algorithm(s) get trained across multiple devices or servers with decentralized data samples without having to exchange the actual data. This approach is radically different from other more established techniques such as getting the data samples uploaded to servers or having data in some form of distributed infrastructure. FL on the other hand generates more robust models without sharing data, leading to privacy-preserved solutions with higher security and access privileges to data. This paper starts by providing an overview of FL. Then, it gives an overview of technical details that pertain to FL enabling technologies, protocols, and applications. Compared to other survey papers in the field, our objective is to provide a more thorough summary of the most relevant protocols, platforms, and real-life use-cases of FL to enable data scientists to build better privacy-preserving solutions for industries in critical need of FL. We also provide an overview of key challenges presented in the recent literature and provide a summary of related research work. Moreover, we explore both the challenges and advantages of FL and present detailed service use-cases to illustrate how different architectures and protocols that use FL can fit together to deliver desired results.

This paper provides a comprehensive systematic literature review (SLR) of various technologies and protocols used for medical Internet of Things (IoT) with a thorough examination of current enabling technologies, use cases, applications, and challenges. Despite recent advances, medical IoT is still not considered a routine practice. Due to regulation, ethical, and technological challenges of biomedical hardware, the growth of medical IoT is inhibited. Medical IoT continues to advance in terms of biomedical hardware, and monitoring figures like vital signs, temperature, electrical signals, oxygen levels, cancer indicators, glucose levels, and other bodily levels. In the upcoming years, medical IoT is expected replace old healthcare systems. In comparison to other survey papers on this topic, our paper provides a thorough summary of the most relevant protocols and technologies specifically for medical IoT as well as the challenges. Our paper also contains several proposed frameworks and use cases of medical IoT in hospital settings as well as a comprehensive overview of previous architectures of IoT regarding the strengths and weaknesses. We hope to enable researchers of multiple disciplines, developers, and biomedical engineers to quickly become knowledgeable on how various technologies cooperate and how current frameworks can be modified for new use cases, thus inspiring more growth in medical IoT.

Big Data Proteogenomics lies at the intersection of high-throughput Mass Spectrometry (MS) based proteomics and Next Generation Sequencing based genomics. The combined and integrated analysis of these two high-throughput technologies can help discover novel proteins using genomic, and transcriptomic data. Due to the biological significance of integrated analysis, the recent past has seen an influx of proteogenomic tools that perform various tasks, including mapping proteins to the genomic data, searching experimental MS spectra against a six-frame translation genome database, and automating the process of annotating genome sequences. To date, most of such tools have not focused on scalability issues that are inherent in proteogenomic data analysis where the size of the database is much larger than a typical protein database. These state-of-the-art tools can take more than half a month to process a small-scale dataset of one million spectra against a genome of 3 GB. In this article, we provide an up-to-date review of tools that can analyze proteogenomic datasets, providing a critical analysis of the techniques’ relative merits and potential pitfalls. We also point out potential bottlenecks and recommendations that can be incorporated in the future design of these workflows to ensure scalability with the increasing size of proteogenomic data. Lastly, we make a case of how high-performance computing (HPC) solutions may be the best bet to ensure the scalability of future big data proteogenomic data analysis.

No abstract

No abstract